Epilepsy in a young adult caused by L-2-hydroxyglutaric aciduria: a case report

Med Princ Pract. 2008;17(3):258-61. doi: 10.1159/000117804. Epub 2008 Apr 10.

Abstract

Objective: To report the importance of a rare organic acid metabolic disorder, L-2-hydroxyglutaric aciduria, and its characteristic neuroimaging cerebral white matter abnormalities in a case of epilepsy.

Subject and methods: A 19-year-old male presented with an 11-year history consisting of school failures, intellectual deterioration and generalized tonic-clonic convulsions.

Results: Neurological examination showed mental subnormality, mild dysarthria and bilateral pyramidal signs. Computed tomography and magnetic resonance imaging (MRI) of the brain showed characteristic white matter lesions, suggestive of L-2-hydroxyglutaric aciduria. The diagnosis of this disease was confirmed by elevated urinary concentrations of L-2-hydroxyglutaric acid. The epilepsy was partially controlled with antiepileptic drugs.

Conclusion: This report indicates the importance of routine examination of urinary organic acids in children and young adults presenting with chronic encephalopathy and epilepsy with characteristic MRI white matter lesions. L-2-hydroxyglutaric aciduria should be considered as one of the differential diagnoses of epilepsy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alcohol Oxidoreductases / urine*
  • Anticonvulsants / therapeutic use
  • Biomarkers / urine
  • Brain Diseases, Metabolic / complications*
  • Brain Diseases, Metabolic / diagnosis*
  • Brain Diseases, Metabolic / physiopathology
  • Brain Diseases, Metabolic / urine
  • Cerebrospinal Fluid
  • Diagnosis, Differential
  • Electroencephalography
  • Epilepsy, Tonic-Clonic / drug therapy
  • Epilepsy, Tonic-Clonic / etiology*
  • Epilepsy, Tonic-Clonic / physiopathology
  • Epilepsy, Tonic-Clonic / urine
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Lysine / metabolism*
  • Magnetic Resonance Imaging
  • Male
  • Psychological Tests
  • Psychometrics
  • Risk Factors

Substances

  • Anticonvulsants
  • Biomarkers
  • Alcohol Oxidoreductases
  • L2HGDH protein, human
  • Lysine